Seema Nair Parvathy - Concepedia

Author

Seema Nair Parvathy

Also Known As

Jeffery Kinney, PARVATHY. S, Parvathy S, Parvathy S., Parvathy, S., Parvathy, Seema Nair, S. Parvathy, S.N. Parvathy, Seema N. Parvathy, Seema Nair Parvathy

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Western University Lawson Health Research Institute St Joseph's Health Care London Health Sciences Centre Centre Hospitalier de l’Université de Montréal

About

Seema Nair Parvathy is an author at Western University specializing in medicine, microbiome, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	442
2	Immunology	2	2	413
3	Microbiology	2	2	57
4	Immunotherapy	1	1	385
5	Intestinal Microbiota	1	1	29

Seema Nair Parvathy

Publications

944

Citations

H-Index

Page 1

	Year	Citations
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Bertrand Routy, John Lenehan, Wilson H. Miller, Nature Medicine Tumor ImmunologyAnti-pd-1 ImmunotherapyCancer ImmunosurveillanceMedicineMelanoma	2023	385
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial Laura J. Craven, Adam Rahman, Seema Nair Parvathy, The American Journal of Gastroenterology	2020	315
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial Kait F. Al, Laura J. Craven, Shaeley Gibbons, Multiple Sclerosis Journal - Experimental Translational and Clinical	2022	73
Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases Laura J. Craven, Seema Nair Parvathy, Justin Tat-Ko, Open Forum Infectious Diseases	2017	53
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease Catherine M Andary, Kait F. Al, John A. Chmiel, Trends in Molecular Medicine DysbiosisIntestinal TransplantationMicrobiologyIntestinal MicrobiotaMicrobiome	2024	29
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma Marina Ninkov, Crystal L. Schmerk, Manoosh Moradizadeh, Cancer Immunology Immunotherapy UrologyDysbiosisKidney TransplantMait Cell FunctionsImmunology	2022	28
1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate) Arielle Elkrief, Siddhartha P. Duttagupta, R. Jamal, Annals of Oncology	2024	15
P864 Combination of fecal microbiota transplantation from healthy donors with anti-PD1 immunotherapy in treatment-naïve advanced or metastatic melanoma patients Saman Maleki, John Lenehan, Jeremy P. Burton, Poster presentations	2020	12
Preventing adverse events in patients with renal cell carcinoma treated with doublet immunotherapy using fecal microbiota transplantation (FMT): Initial results from perform a phase I study. Ricardo Fernandes, Seema Nair Parvathy, D. Scott Ernst, Journal of Clinical Oncology	2022	12
Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma. Wilson H. Miller, Bertrand Routy, Rahima Jamal, Journal of Clinical Oncology	2022	11

Page 1